Personalis
The firm shared performance study results at a recent meeting and said it has begun processing samples for its first major pharma customer.Â
Personalis, UCSD Cancer Center Ink Clinical Genomic Testing, Research Partnership
The company will provide comprehensive genomic tumor testing and will work with UCSD researchers to develop new biomarkers and test its new liquid biopsy assay.
Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration
Investigators intend to offer Personalis' comprehensive genomics testing to consenting patients for both clinical use and to aggregate data for ongoing research.
In Brief This Week: Biodesix, Avisa Diagnostics, Mount Sinai, Sophia Genetics, and More
News items for the in vitro diagnostics industry for the week of Aug. 23, 2021.
MapKure, Personalis Partner to Screen Patients for BRAF Inhibitor Trial
Personalis plans to develop a companion diagnostic to MapKure's BRAF inhibitor, BGB-3245, once biomarkers have been identified in the study.
Sep 25, 2019